Could a common Alzheimer's drug boost brain training in schizophrenia?

This study tested whether adding the drug memantine to a computer-based cognitive training program improves thinking and daily function in people with schizophrenia or schizoaffective disorder. 62 adults took part in a double-blind trial where some received memantine plus training and others received a placebo plus training. The goal was to see if memantine could enhance the benefits of cognitive training on symptoms, disability, and cognitive test scores.